- Report
- August 2023
- 96 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- July 2024
- 156 Pages
Global
From €3807EUR$4,250USD£3,245GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1344EUR$1,500USD£1,145GBP
- Report
- December 2021
Global
From €4344EUR$4,850USD£3,703GBP
- Report
- November 2024
Global, Europe, United States, ... Global, Europe, United States, Japan
From €4031EUR$4,500USD£3,436GBP
- Report
- October 2024
Global
From €3135EUR$3,500USD£2,672GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2463EUR$2,750USD£2,100GBP
- Report
- March 2021
- 197 Pages
Global
From €3135EUR$3,500USD£2,672GBP
- Report
- July 2024
- 132 Pages
Global
From €851EUR$950USD£725GBP
- Report
- March 2024
- 132 Pages
Global
From €851EUR$950USD£725GBP
The Influenza Test market is a subset of the larger Infectious Disease Testing market. It is used to detect the presence of the influenza virus in a patient's sample. Tests can be conducted using a variety of methods, including rapid antigen tests, molecular tests, and serological tests. Rapid antigen tests are the most commonly used, as they provide results in a short amount of time. Molecular tests are more accurate, but take longer to process. Serological tests are used to detect antibodies to the virus, and are used to diagnose past infections.
The Influenza Test market is highly competitive, with many companies offering a variety of tests. Some of the major players in the market include Abbott, Becton Dickinson, Roche, Quidel, and Cepheid. Show Less Read more
